BMO Capital Markets adjusted its price target for FactSet Research Systems (NYSE:FDS) shares, lowering it to $498.00 from the previous $518.00, but retained a Market Perform rating on the stock.

The increase was mostly due to higher Medicaid medical-cost trends. The number was just below the FactSet consensus of 92.5%. “While rates today remain insufficient to cover the elevated level of cost ...